EUPRO - A reference database on project-based R&D collaboration networks.

The EUPRO database enables the analysis of participation patterns of organisations in and across different European R&D funding initiatives and the investigation of resulting collaborative R&D network structures and dynamics. The perimeter of EUPRO is currently more than 600,000 R&D projects funded by European (EU, transnational or national) research funding organisations, comprising systematic information about contents of the R&D projects, their participating organizations (including organisation type and location), and a number of additional characteristics (e.g.

The geographical dynamics of global R&D collaboration networks in robotics: Evidence from co-patenting activities across urban areas worldwide.

The focus of this study is on the geography of robotics Research and Development (R&D) activities. The objectives are, first, to identify hotspots in robotics R&D worldwide, and second, to characterise structures and dynamics of global robotics R&D collaboration networks through detailed geographical lenses of global urban areas. We use patents as marker for R&D activities, and accordingly focus on technologically oriented R&D, drawing on information from patents applied for between 2002 and 2016.

Global landscape of patents related to human coronaviruses.

At present, the COVID-19 pandemic is running rampant, having caused 2.18 million deaths. Characterizing the global patent landscape of coronaviruses is essential not only for informing research and policy, given the current pandemic crisis, but also for anticipating important future developments.

The dynamics of global R&D collaboration networks in ICT: Does China catch up with the US?

The purpose of this study is to identify and characterize the structure and dynamics of global R&D collaboration networks in ICT by analyzing cross-country co-patents, with a special focus on the role of China. We employ a Social Network Analysis (SNA) perspective, using information on more than 77 thousand co-patents from 2001-2015. These co-patents are disaggregated by three time periods and four ICT subsectors.

China's landscape in oncology drug research: perspectives from research collaboration networks.

Objective: Better understanding of China's landscape in oncology drug research is of great significance for discovering anti-cancer drugs in future. This article differs from previous studies by focusing on Chinese oncology drug research communities in co-publication networks at the institutional level. Moreover, this research aims to explore structures and behaviors of relevant research units by thematic community analysis and to address policy recommendations.

Is the United States still dominant in the global pharmaceutical innovation network?

The dramatic growth of research and development activities in the pharmaceutical sector in emerging economies raises the question of whether the United States still keeps its dominant role in the global pharmaceutical innovation landscape. This paper focuses on investigating the role of the United States in global pharmaceutical innovation, and differs from previous studies by shifting attention to a network analytic perspective to track the global distribution of pharmaceutical inventions. Our sample is composed of key patents covering all new drugs approved by the Food and Drug Administration between 1996 and 2010.